Literature DB >> 2421936

Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

A G Bosanquet.   

Abstract

The methods used to test drug stability are discussed in the light of two recent publications using biological assays. It is concluded that, as far as possible, stability-indicating assays should be used so that possible false results do not lead to erroneous conclusions. Many of the results of the stability studies with adriamycin were found to be at variance with each other, with a 20-fold difference in stability being reported in one case by different groups from virtually identical experiments. Definitive statements about adriamycin stability are therefore impossible, but it is clear that it is sensitive to light, adsorbs to membrane filters and containers (except polypropylene and siliconised glass), chelates metal ions and probably degrades rapidly in medium. Adriamycin's analogues may well have the same spectrum of sensitivity. Bleomycin, actinomycin D and neocarzinostatin were found to be stable for greater than or equal to 2 weeks at room temperature. All the other antitumour antibiotics investigated (except rubidazone) are stable for greater than or equal to 24 h at room temperature and longer at 5 degrees C. Almost all of them are sensitive to light and are most stable in neutral or slightly acid media, and many of them adsorb to membrane filters. They can probably all be stored frozen in solution.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421936     DOI: 10.1007/bf00299858

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  96 in total

1.  Structure of the antitumor protein neocarzinostatin. Purification, amino acid composition, disulfide reduction, and isolation and composition of tryptic peptides.

Authors:  H Maeda; C B Glaser; J Czombos; J Meienhoffer
Journal:  Arch Biochem Biophys       Date:  1974-10       Impact factor: 4.013

2.  Pharmacologic pitfalls in the human tumor clonogenic assay.

Authors:  D S Alberts; J Einspahr; R Ludwig; S E Salmon
Journal:  Recent Results Cancer Res       Date:  1984

3.  Stability of doxorubicin in relation to chemosensitivity determinations: loss of lethality and retention of antiproliferative activity.

Authors:  E J Pavlik; D E Kenady; J R van Nagell; M B Hanson; E S Donaldson; S Casper; D Garrett; D Smith; K Keaton; R C Flanigan
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

4.  Possible incompatibility of doxorubicin hydrochloride with aluminum.

Authors:  W A Gardiner
Journal:  Am J Hosp Pharm       Date:  1981-09

5.  Ultraviolet photoirradiation of daunomycin and DNA daunomycin complexes.

Authors:  P J Gray; D R Phillips
Journal:  Photochem Photobiol       Date:  1981-03       Impact factor: 3.421

6.  Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin.

Authors:  S E Salmon; L Young; B Soehnlen; R Liu
Journal:  J Clin Oncol       Date:  1984-04       Impact factor: 44.544

7.  Rapid quantitative determination of seven anthracyclines and their hydroxy metabolites in body fluids.

Authors:  M J Oosterbaan; R J Dirks; T B Vree; E van der Kleijn
Journal:  J Chromatogr       Date:  1984-03-09

8.  Bleomycin hydrolase activity and cytotoxicity in human tumors.

Authors:  J S Lazo; C J Boland; P E Schwartz
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

9.  Phase I trial of aclacinomycin-A. A clinical and pharmacokinetic study.

Authors:  C Karanes; J D Young; M K Samson; L B Smith; L A Franco; L H Baker
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

10.  Stability of anthracycline antitumor agents in four infusion fluids.

Authors:  G K Poochikian; J C Cradock; K P Flora
Journal:  Am J Hosp Pharm       Date:  1981-04
View more
  14 in total

1.  Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.

Authors:  T Dine; J C Cazin; B Gressier; M Luyckx; C Brunet; M Cazin; F Goudaliez; M L Mallevais; I Toraub
Journal:  Pharm Weekbl Sci       Date:  1992-12-11

2.  Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus.

Authors:  Theresa Currier Thomas; Joshua A Beitchman; Francois Pomerleau; Teresa Noel; Paiboon Jungsuwadee; D Allan Butterfield; Daret K St Clair; Mary Vore; Greg A Gerhardt
Journal:  Brain Res       Date:  2017-07-11       Impact factor: 3.252

Review 3.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. III. Antimetabolites, tubulin-binding agents, platinum drugs, amsacrine, L-asparaginase, interferons, steroids and other miscellaneous antitumor agents.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Test for chemotherapeutic sensitivity of cerebral gliomas: use of the colorimetric MTT assay.

Authors:  J C Tonn; G Nikkhah; J L Darling; W Schachenmayr
Journal:  J Neurooncol       Date:  1993-05       Impact factor: 4.130

5.  Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time.

Authors:  S Chevillard; P Vielh; G Bastian; J Coppey
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

6.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; R Schönmayr; W Schachenmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

7.  Chlorambucil: stability of solutions during preparation and storage.

Authors:  A G Bosanquet; H E Clarke
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 8.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 9.  A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions.

Authors:  D A Williams; J Lokich
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Adriamycin-induced inhibition of melanoma cell invasion is correlated with decreases in tumor cell motility and increases in focal contact formation.

Authors:  L A Repesh; S R Drake; M C Warner; S W Downing; R Jyring; E A Seftor; M J Hendrix; J B McCarthy
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.